Cargando…

Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone

Here, we describe a protocol that provides the steps required for the generation of a mouse model of polycystic ovary syndrome (PCOS) by exposing dams to elevated levels of anti-Müllerian hormone during late gestation. This protocol also describes the steps required to assess the PCOS-like equivalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Mimouni, Nour El Houda, Giacobini, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348292/
https://www.ncbi.nlm.nih.gov/pubmed/34401772
http://dx.doi.org/10.1016/j.xpro.2021.100684
_version_ 1783735304025276416
author Mimouni, Nour El Houda
Giacobini, Paolo
author_facet Mimouni, Nour El Houda
Giacobini, Paolo
author_sort Mimouni, Nour El Houda
collection PubMed
description Here, we describe a protocol that provides the steps required for the generation of a mouse model of polycystic ovary syndrome (PCOS) by exposing dams to elevated levels of anti-Müllerian hormone during late gestation. This protocol also describes the steps required to assess the PCOS-like equivalents of the Rotterdam PCOS diagnostic criteria in mice. For complete details on the use and execution of this protocol, please refer to Tata et al. (2018) and Mimouni et al. (2021).
format Online
Article
Text
id pubmed-8348292
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83482922021-08-15 Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone Mimouni, Nour El Houda Giacobini, Paolo STAR Protoc Protocol Here, we describe a protocol that provides the steps required for the generation of a mouse model of polycystic ovary syndrome (PCOS) by exposing dams to elevated levels of anti-Müllerian hormone during late gestation. This protocol also describes the steps required to assess the PCOS-like equivalents of the Rotterdam PCOS diagnostic criteria in mice. For complete details on the use and execution of this protocol, please refer to Tata et al. (2018) and Mimouni et al. (2021). Elsevier 2021-07-31 /pmc/articles/PMC8348292/ /pubmed/34401772 http://dx.doi.org/10.1016/j.xpro.2021.100684 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Protocol
Mimouni, Nour El Houda
Giacobini, Paolo
Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone
title Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone
title_full Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone
title_fullStr Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone
title_full_unstemmed Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone
title_short Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone
title_sort polycystic ovary syndrome mouse model by prenatal exposure to high anti-müllerian hormone
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348292/
https://www.ncbi.nlm.nih.gov/pubmed/34401772
http://dx.doi.org/10.1016/j.xpro.2021.100684
work_keys_str_mv AT mimouninourelhouda polycysticovarysyndromemousemodelbyprenatalexposuretohighantimullerianhormone
AT giacobinipaolo polycysticovarysyndromemousemodelbyprenatalexposuretohighantimullerianhormone